A habênula é uma estrutura epitalâmica diferenciada em dois complexos nucleares, a habênula medial (MHb) e a habênula lateral (LHb). Recentemente, a MHb junto com seu alvo principal, o núcleo interpeduncular (IP), foram identificados como estruturas chaves envolvidas na mediação dos efeitos aversivos da nicotina. Contudo, estruturas intimamente interligadas com o eixo MHb-IP, como o núcleo mediano (MnR), a parte caudal do núcleo dorsal da rafe (DRC), e o núcleo tegmental laterodorsal (LDTg) podem contribuir para os efeitos comportamentais da nicotina. As conexões aferentes e eferentes do IP, até agora, não foram sistematicamente investigadas com traçadores sensíveis. Assim, realizamos injeções de traçadores retrógrados ou anterógrados em diferentes subdivisões do IP, no MnR, ou LDTg e também examinamos a assinatura neuroquímica de algumas das mais proeminentes aferências dessas três estruturas através da combinação de rastreamento retrógrada com métodos de imunofluorescência e hibridização in situ. Além de receber entradas topograficamente organizadas da MHb e também da LHb, observamos que o IP está principalmente interligado de forma recíproca com estruturas da linha média, incluindo o MnR/DRC, o núcleo incerto, o núcleo supramamilar, o septo e o LDTg. As conexões bidirecionais entre o IP e o MnR assim como as entradas do LDTg para o IP provaram de ser principalmente GABAérgicas. Com respeito a uma possível topografia das saídas do IP, todos os subnúcleos do IP deram origem a projeções descendentes, enquanto as suas projeções ascendentes, incluindo projeções focais para o hipocampo ventral, o septo ventrolateral, e a LHb originaram da região dorsocaudal do IP. Nossos resultados indicam que o IP está intimamente associado a uma rede de estruturas da linha média, todos eles considerados moduladores chave da atividade teta do hipocampo. Assim, o IP forma um elo que liga MHb e LHb com esta rede e com o hipocampo. Além disso, as proeminentes interconexões predominantemente GABAérgicas entre IP e MnR, assim como IP e LDTg, suportam um papel chave dessas vias bidirecionais na resposta comportamental à nicotina. / The habenula is an epithalamic structure differentiated into two nuclear complexes, medial (MHb) and lateral habenula (LHb). Recently, MHb together with its primary target, the interpeduncular nucleus (IP), have been identified as major players in mediating the aversive effects of nicotine. However, structures downstream of the MHb-IP axis, including the median (MnR), caudal dorsal raphe nucleus (DRC), and the laterodorsal tegmental nucleus (LDTg), may contribute to the behavioral effects of nicotine. The afferent and efferent connections of the IP have hitherto not been systematically investigated with sensitive tracers. Thus, we placed injections of retrograde or anterograde tracers into different IP subdivisions, the MnR, or LDTg and additionally examined the transmitter phenotype of some major IP and MnR afferents by combining retrograde tract tracing with immunofluorescence and in situ hybridization techniques. Besides receiving topographically organized inputs from MHb and also LHb, we found that the main theme of IP connectivity are strong reciprocal interconnections with midline structures, including the MnR/DRC, nucleus incertus, supramammillary nucleus, septum, and LDTg. The bidirectional connections between IP and MnR and the LDTg inputs to the IP proved to be mostly GABAergic. Regarding a possible topography of IP outputs, all IP subnuclei gave rise to descending projections, whereas ascending projections, including focal projections to the ventral hippocampus, ventrolateral septum, and LHb mostly originated from the dorsocaudal IP. Our findings indicate that IP is closely associated to a distributed network of midline structures, all of them considered key modulators of hippocampal theta activity. Thus, IP forms a node that links MHb and LHb with this network and the hippocampus. Moreover, the rich predominantly GABAergic interconnections between IP and MnR, as well as IP and LDTg, support a cardinal role of these bidirectional pathways in the behavioral response to nicotine.

The CHRNA5/A3/B4 genomic cluster encodes for the alpha5, alpha3 and beta4 subunits of the nicotinic acetylcholine receptors (nAChRs). Human genetic studies have revealed a significant association of variants in this genomic region with nicotine dependence. However, the mechanisms through which overexpression of these three subunits may influence smoking-related behaviours is not understood. To gain insight in the possible mechanisms, we used a BAC transgenic mouse model overexpressing this cluster containing the three genes together with their transcriptional regulatory elements. We found that overexpression of the cluster: i) increases sensitivity to the pharmacological effects of nicotine; ii) modifies particular cognitive domains associated to drug addiction and hippocampal neuronal complexity and synaptic plasticity; and iii) shifts the rewarding and aversive properties of nicotine and the manifestation of nicotine-withdrawal syndrome. Our study suggests that the genomic cluster CHRNA5/A3/B4 contributes to genetic vulnerability to nicotine addiction and promotes smoking-related behaviours possibly through hippocampal plasticity changes. / El cluster genòmic CHRNA5/A3/B4 codifica per les subunitats alfa5, alfa3 i beta4 dels receptors d’acetilcolina (nAChRs). Estudis de genètica humana han revelat que variants en aquesta regió genòmica estan significativament associats a la dependencia a nicotina. Malauradament, els mecanismes pels quals la sobreexpressió d’aquestes tres subunitats influencia comportaments relacionats amb el consum de tabac no són del tot coneguts. Per tal d’entendre els possibles mecanismes, hem utilitzat un model de ratolí transgènic que sobreexpressa aquest cluster amb els tres gens i les seus elements de regulació transcripcional. Hem trobat que la sobreexpressió del cluster: i) incrementa la sensibilitat als efectes farmacològics de la nicotina; ii) modifica determinats dominis cognitius associats a l’addicció a droges i la complexitat neuronal i plasticitat sinàpica de l’hipocamp; a més a més iii) canvia les propietats de recompensa i aversió de la nicotina i la manifestació del síndrome d’abstinència. El nostre estudi suggereix que el cluster genòmic CHRNA5/A3/B4 contribueix a la vulnerabilitat genètica a l’adicció a la nicotina i promou comportaments relacionats amb el consum de tabac possiblement a través de canvis de plasticitiat a l’hipocamp.

Nicotine dependence is responsible for perpetuating the adverse health effects due to tobacco use, the leading cause of preventable death worldwide. Nicotine is an agonist for nicotinic acetylcholine receptors, which are enriched in the mesocorticolimbic and habenulo-interpeduncular circuitries, underlying nicotine reward and withdrawal, respectively. Drugs of abuse, including nicotine, induce stable neuroadaptations, requiring protein synthesis through regulation of transcription factors, epigenetic mechanisms, and non-coding RNAs. It also been shown that miRNAs in brain are regulated by nicotine and that miRNA dysregulation contributes to brain dysfunction, including drug addiction. While much is known about the neurocircuitry responsible for the behaviors associated with nicotine reward or withdrawal, the underlying molecular mechanisms of how these changes in behavior are induced are less clear. Using miRNA-/mRNA-Seq, we demonstrate that there are widespread changes in both miRNA and mRNA expression in brain regions comprising the mesocorticolimbic circuit after chronic nicotine treatment, and the habenulo-interpeduncular circuit during acute nicotine withdrawal. Conserved, differentially expressed miRNAs were predicted to target inversely regulated mRNAs. We determined that expression of miR-106b-5p is up-regulated and Profilin 2 (Pfn2), an actin-binding protein enriched in the brain, is down-regulated in the interpeduncular nucleus (IPN) during acute nicotine withdrawal. Further we show that miR-106b-5p represses Pfn2 expression. We demonstrate that knockdown of Pfn2 in the IPN is sufficient to induce anxiety, a symptom of withdrawal. This novel role of Pfn2 in nicotine withdrawal-associated anxiety is a prime example of this dataset’s utility, allowing for the identification of a multitude of miRNAs/mRNA which may participate in the molecular mechanisms underlying the neuroadaptations of nicotine dependence.